ReviewaBIOTECH2026
Harnessing mitochondrial genome editing for crop improvement: principles and applications.
Review in aBIOTECH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assembly and Comparative Analysis of the Complete Mitochondrial Genome ofCurrent issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant mitochondria possess a genome that not only encodes genes essential for respiration and energy production but also influences important traits such as cytoplasmic male sterility (CMS). However, the manipulation of mitochondrial DNA (mtDNA) has long been challenging. Recent breakthroughs in protein-based editing tools, beginning with Transcription Activator-Like Effector Nucleases (TALENs) and extending to TALEN gene-drive mutagenesis (TALEN-GDM) and, most recently, TALE-based base editors, have helped overcome some of these barriers. Nevertheless, mitochondrial transformation remains a significant limitation. Promising developments in this field come from nanotechnology and peptide engineering. In this review, we systematically compare these emerging tools, with a focus on the mechanisms responsible for their distinct editing outcomes and inheritance patterns, while critically examining current limitations and propo sing potential strategies to overcome them. We assess persistent challenges in plant mitochondrial transformation. Furthermore, we detail how mitochondrial genome editing is advancing research on cytoplasmic male sterility, which has the potential to facilitate crop breeding. Finally, we outline how CRISPR is expected to enrich the editing toolbox and discuss potential uses of mitochondrial genome engineering to expand our understanding of mitochondrial biology and provide novel opportunities for crop improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.